This trial is testing PET/MRI to see if it can accurately detect and characterize cancerous tumors, compared to the reference standard PET/CT.
- Blood Cancers
1 Primary · 2 Secondary · Reporting Duration: 2 years
1 Treatment Group
1 of 1
20 Total Participants · 1 Treatment Group
Primary Treatment: PET-MRI · No Placebo Group · N/A
Who is running the clinical trial?
Age 5 - 18 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Who fulfills the requirements to be considered a participant in this clinical experiment?
"To qualify for this medical trial, applicants must have a hematologic neoplasm and fit within the age range of 5 to 18. A total of 20 people are slated to be recruited." - Anonymous Online Contributor
Is there an ongoing recruitment period for this research project?
"Based on the information provided by clinicaltrials.gov, this trial is still enrolment participants and was last modified on August 30th 2021 - since it's initial post of October 1st 2012." - Anonymous Online Contributor
To what capacity is the current trial recruiting participants?
"Affirmative. According to information available on clinicaltrials.gov, this medical trial is still recruiting participants; the listing was published on October 1st 2012 and most recently updated August 30th 2021. This research requires 20 patients from one site location." - Anonymous Online Contributor
Does this research project admit individuals over the age of fifty?
"The lowest age of admission to this trial is 5 years old and the upper limit is 18." - Anonymous Online Contributor